BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 24606815)

  • 1. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
    Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
    Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
    Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
    Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
    Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.
    Jiang W; Chamberlain PD; Garden AS; Kim BY; Ma D; Lo EJ; Bell D; Gunn GB; Fuller CD; Rosenthal DI; Beadle BM; Frank SJ; Morrison WH; El-Naggar AK; Glisson BS; Sturgis EM; Phan J
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1459-66. PubMed ID: 26560893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.